Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues

Affiliations

Azar Baradaran. J Nephropathol. 2012 Oct.

. 2012 Oct;1(3):126-9.

doi: 10.5812/nephropathol.8107. Epub 2012 Oct 1.

¹ Department of Clinical Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.

No abstract available

Keywords: Diabetic nephropathy; Lipoprotein(a); Renal failure.

Cited by

Medicinal Plants and New Concerns in Statin Consumption.
Nasri H, Rafieian-Kopaei M. Nasri H, et al. Iran J Public Health. 2013 Sep;42(9):1071-2. Iran J Public Health. 2013. PMID: 26060670 Free PMC article. No abstract available.
Protective effects of metformin on renal tubular cells.
Rafieian Kopaei M, Baradaran A. Rafieian Kopaei M, et al. Iran Red Crescent Med J. 2014 Sep 5;16(9):e11662. doi: 10.5812/ircmj.11662. eCollection 2014 Sep. Iran Red Crescent Med J. 2014. PMID: 25593707 Free PMC article. No abstract available.
NORMAL FEMORAL ARTERY INTIMA-MEDIA THICKNESS AMONG HEALTHY NIGERIAN ADULTS; RELATIONSHIP WITH AGE, GENDER AND BODY MASS INDEX.
Soneye MA, Adekanmi AJ. Soneye MA, et al. J West Afr Coll Surg. 2018 Oct-Dec;8(4):67-93. J West Afr Coll Surg. 2018. PMID: 33553052 Free PMC article.
Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus.
Ojha A, Ojha U, Mohammed R, Chandrashekar A, Ojha H. Ojha A, et al. Clin Pharmacol. 2019 May 9;11:57-65. doi: 10.2147/CPAA.S202614. eCollection 2019. Clin Pharmacol. 2019. PMID: 31191043 Free PMC article. Review.
Association between serum uric acid, urinary albumin excretion, and glycated hemoglobin in Type 2 diabetic patient.
Neupane S, Dubey RK, Gautam N, Agrawal KK, Jayan A, Shrestha S, Jha AC. Neupane S, et al. Niger Med J. 2016 Mar-Apr;57(2):119-23. doi: 10.4103/0300-1652.182074. Niger Med J. 2016. PMID: 27226687 Free PMC article.

1. Nasri H, Baradaran A. Association of serum lipoprotein(a) with ultrasonographically determined early atherosclerotic changes in the carotid and femoral arteries in kidney transplanted patients. Transplant Proc . 2004;36(9):2683–6. - PubMed
1. Baradaran A, Nasri H, Ganji F. Association of serum lipoprotein(a) with intimae-media thickness as a target-organ damage in essential hypertensive patients. Iran Heart J 2004;5:55-63. http://www.sid.ir/en/VEWSSID/J_pdf/86820040304.pdf.
1. Baradaran A, Nasri H, Ganji F . Close relationship of serum lipoprotein (a) with ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery in end-stage renal failure patients undergoing hemodialysis. Timok Med J (Journal of Regional Section of Serbian Medical Association in Zajecar) 2004;29(1):8-13. http://www.tmg.org.rs/v290102e.htm
1. Nasri H, Baradaran A. Association of Early Atherosclerotic Vascular Changes with Serum Lipoprotein (a) in Predialysis Chronic Renal Failure and Maintenance Hemodialysis Patients. Saudi J Kidney Dis Transpl . 2005;16(2):154–60. - PubMed
1. Baradaran A, Nasri H . Association of serum lipoprotein(a) with left ventricular hypertrophy in hemodialysis patients. Indian J Nephrol 2004;14:41-5. http://medind.nic.in/iav/t04/i2/iavt04i2p41.pdf